QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PODD

QT69Insulet Corporation
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
145.76
+2.24+1.56%
OverviewShort InterestFilings
PODDQT69Insulet Corporation·NASDAQ
OverviewShort InterestFilings
145.76+1.56%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E33.17EPS (ttm)4.30
Insider Own0.87%
Shs Outstand69.26M
Perf Week-2.30%
Market Cap9.94BForward P/E17.97EPS next Y8.11Insider Trans0.01%Shs Float-Perf Month-5.72%
Enterprise Value10.41BPEG-EPS next Q1.45Inst Own-Short Float-Perf Quarter-36.25%
Income299.22MP/S3.43EPS this Y50.79%Inst Trans-Short Ratio-Perf Half Y-49.52%
Sales2.90BP/B7.71EPS next Y25.14%ROA10.14%Short Interest-Perf YTD-48.72%
Book/sh18.81P/C16.22EPS next 5Y22.26%ROE21.38%52W High354.91 -58.93%Perf Year-52.11%
Cash/sh6.93P/FCF24.12EPS past 3/5Y-ROIC16.39%52W Low140.63 3.65%Perf 3Y-
Dividend Est.-EV/EBITDA18.10Sales past 3/5Y27.55% 24.54%Gross Margin71.01%Volatility2.49% 3.15%Perf 5Y-
Dividend TTM-EV/Sales3.59EPS Y/Y TTM-6.92%Oper. Margin17.48%ATR (14)6.68Perf 10Y-
Dividend Ex-Date-Quick Ratio1.81Sales Y/Y TTM40.01%Profit Margin10.44%RSI (14)41.35Recom2.33
Dividend Gr. 3/5Y-Current Ratio2.49EPS Q/Q39.22%SMA20-2.12%Beta0.47Target Price223.15
Payout0.00%Debt/Eq0.73Sales Q/Q33.92%SMA50-11.71%Rel Volume1.92Prev Close143.52
Employees5,400LT Debt/Eq0.68EarningsAug 06SMA200-43.16%Avg Volume1.49MPrice145.76
IPO DateMay 15, 2007Option/ShortYes / YesEPS/Sales Surpr.19.33% 4.38%Net Debt/EBITDA0.81Volume2,863,931Change1.56%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedUBSBuy$250 → $219
Jun-11-26ReiteratedTruist Financial$250 → $219
Jun-08-26ReiteratedRaymond JamesOutperform$263 → $216
May-27-26ReiteratedGoldman SachsBuy$237 → $205
May-07-26ReiteratedGoldman SachsBuy$277 → $237
May-07-26ReiteratedTruist Financial$315 → $250
May-07-26ReiteratedEvercore ISI$240 → $200
May-07-26ReiteratedStifel Nicolaus$350 → $250
May-07-26ReiteratedRBC CapitalOutperform$325 → $280
May-07-26ReiteratedCanaccord GenuityBuy$435 → $249
Latest News
Jun-15-26
Jun-15-2606:38PM
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock ScreenerYahoo
12:44PM
2 S&P 500 Stocks to Target This Week and 1 That UnderwhelmYahoo
Jun-12-26
Jun-12-2607:12PM
Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting TranscriptSeekingAlpha
10:17AM
Truist Securities Maintains Buy on Insulet, Lowers Price Target to $219Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,9012,7082,072
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A841768626
Gross Profit2,0601,9401,446
Selling, General and Administrative Excl. Other1,2211,165917
Research and Development331301220
Other Operating Expense000
Operating Income507474309
Interest Expense718043
Unusual Expense
———
Non-Operating Income (Expense)3355-34
Net Income Before Taxes404340300
Income Taxes10292-118
Consolidated Net Income304247418
Net Income From Continuing Operations304247418
Net Income304247418
EPS (Recurring)4.313.515.97
EPS (Basic, Before Extraordinaries)4.313.515.97
EPS (Diluted)4.303.485.78
EBITDA574532424
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio33.9081.68—
Price To Sales Ratio3.527.35—
Gross Margin71.0171.6469.79
Operating Margin17.4817.5014.91
Net Margin10.489.1220.17
Shares Outstanding707070
Market Capitalization10,20319,897—
Operating Lease Expense
———
Insider Trading Volume
$161.55$137.13$112.70$88.28$63.86● Close Price0.00M0.46M0.92M1.38M1.85MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BORIO LUCIANADirectorJun 03 '26Sale143.2741859,8874,329Jun 04 12:00 AM
STONESIFER TIMOTHY C.DirectorJun 03 '26Buy143.512,790400,3939,041Jun 04 12:00 AM
MINOGUE MICHAEL RDirectorFeb 25 '26Buy246.232,030499,84717,483Feb 26 12:00 AM
McEvoy AshleyPresident and CEOFeb 20 '26Buy239.354,3001,029,20513,916Feb 23 12:00 AM
Frederick Wayne A.I.DirectorDec 15 '25Sale293.091,851542,5102,158Dec 16 12:00 AM
STONESIFER TIMOTHY C.DirectorDec 05 '25Buy311.73962299,8844,591Dec 08 12:00 AM
Singh PremSVP, Global OperationsSep 08 '25Sale347.49687238,7263,456Sep 09 12:00 AM
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Option Exercise241.111,594384,3274,687Sep 09 12:00 AM
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Sale348.81797278,0023,890Sep 09 12:00 AM
Benjamin EricEVP, CPXOAug 21 '25Sale332.234,2631,416,29616,736Aug 22 12:00 AM
Singh PremSVP, Global OperationsAug 07 '25Option Exercise271.282,686728,6505,486Aug 08 12:00 AM
Singh PremSVP, Global OperationsAug 07 '25Sale320.001,343429,7604,143Aug 08 12:00 AM
Singh PremSVP, Global OperationsJun 13 '25Option Exercise166.622,514418,8826,470Jun 16 12:00 AM
Singh PremSVP, Global OperationsJun 13 '25Sale300.052,327698,2164,143Jun 16 12:00 AM
Manea DanSVP, Chief HR OfficerJun 13 '25Sale300.051,300390,0659,090Jun 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR